Citadel Advisors
DCTH icon

Citadel Advisors’s Delcath Systems DCTH Stock Holding History

Citadel Advisors’s Portfolio DCTH Stock Details DCTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$717K Sell
77,264
-291,601
-79% -$2.82M ﹤0.01% 8449
2025
Q4 		$3.73M Sell
368,865
-80,450
-18% -$800K ﹤0.01% 4782
2025
Q3 		$4.83M Sell
449,315
-353,893
-44% -$3.95M ﹤0.01% 4422
2025
Q2 		$10.9M Buy
803,208
+677,656
+540% +$9.45M ﹤0.01% 2909
2025
Q1 		$1.6M Sell
125,552
-164,049
-57% -$2.33M ﹤0.01% 5967
2024
Q4 		$3.49M Buy
289,601
+135,640
+88% +$1.43M ﹤0.01% 4586
2024
Q3 		$1.39M Buy
153,961
+1,039
+0.7% +$9.02K ﹤0.01% 6201
2024
Q2 		$1.28M Buy
152,922
+110,013
+256% +$697K ﹤0.01% 6130
2024
Q1 		$205K Sell
42,909
-14,276
-25% -$61.6K ﹤0.01% 10278
2023
Q4 		$238K Buy
57,185
+56,154
+5,447% +$184K ﹤0.01% 9610
2023
Q3 		$4.18K Sell
1,031
-17,342
-94% -$81.3K ﹤0.01% 13509
2023
Q2 		$107K Buy
+18,373
New +$115K ﹤0.01% 10831
2023
Q1 		– Sell
-24,188
Closed -$87.1K – 14842
2022
Q4 		$87.1K Buy
+24,188
New +$74.1K ﹤0.01% 11407

Other funds holding DCTH

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAC
Private Wealth Advisors (California) Fresno, California $356M AUM 26.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Citadel Advisors's DCTH Position: Q1 2026 in Review

Citadel Advisors reduced its Delcath Systems (DCTH) stake by 79% in Q1 2026, selling an estimated $2.82M and leaving 77,264 shares worth $717K. The position accounts for ﹤0.01% of the portfolio, ranked #8449.

Citadel Advisors first reported a position in DCTH in Q4 2022 and has held it in 13 quarters since. The position peaked at $10.9M in Q2 2025. 121 funds tracked by Wall St. Rank hold DCTH as of Q1 2026.

  • Citadel Advisors held 77,264 shares of Delcath Systems worth $717K as of Q1 2026.
  • Citadel Advisors sold 291,601 Delcath Systems shares in Q1 2026, an estimated $2.82M.
  • Delcath Systems made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #8449 holding.
  • Citadel Advisors first reported a position in Delcath Systems in Q4 2022 and has held it in 13 quarters since.
  • Citadel Advisors's Delcath Systems position peaked at $10.9M in Q2 2025.
  • 121 funds tracked by Wall St. Rank held Delcath Systems as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.